RXRX

Recursion Pharmaceuticals (RXRX) Investor Questions

Recursion Pharmaceuticals (RXRX) investor questions: stock forecasts, price data, dividends, earnings dates, valuation and risk, with missing data clearly identified.

Research record updated: . Individual measures may refer to different reporting periods.

Company
Recursion Pharmaceuticals
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
43
Annual revenue
$74.68M
Annual net income
$-644.76M
Annual free cash flow
$-378.28M

Recursion Pharmaceuticals (RXRX) Investor Questions research

Recursion Pharmaceuticals trades under the ticker RXRX. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review RXRX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.

What is Recursion Pharmaceuticals (RXRX) stock?

Recursion Pharmaceuticals trades under ticker RXRX. Its recorded sector is Healthcare. Its industry is Biotechnology.

What does the RXRX stock forecast mean?

BTI's forecast summarizes available short-term and long-term research scores for RXRX. These scores are not price targets, analyst consensus or probabilities of a positive return. Compare the Forecast, Earnings and Valuation pages before interpreting the outlook.

Where can I find the RXRX stock price today?

Check the RXRX quote and chart in the research workspace, including currency, trading session and quote timestamp. The research-record update time on this page is not a live quote timestamp.

Does RXRX pay dividends?

Dividend yield is not supplied in this RXRX research record. Missing data does not establish that Recursion Pharmaceuticals does not pay dividends. Check the company's dividend announcements for declared amounts and dates.

When does RXRX report earnings?

The available earnings record lists 2026-08-05 for RXRX. This stored date may be historical; it is not confirmation of the next announcement. Check Recursion Pharmaceuticals's investor-relations calendar for the current schedule; estimated dates can change.

How can I assess RXRX's valuation and risk?

Compare Recursion Pharmaceuticals's financial results, cash flow, debt and valuation assumptions with its operating risks and competitors. The Financials, Valuation and Statistics pages provide the available figures. A BTI score is a research input, not a personalized recommendation.